Skip to main content
Erschienen in: Cancer Causes & Control 5/2009

01.07.2009 | Original Paper

Delayed exposure to infections and childhood lymphomas: a case–control study

verfasst von: A. Michos, N. Dessypris, A. Pourtsidis, M. Moschovi, S. Polychronopoulou, F. Athanasiadou-Piperopoulou, M. Kalmanti, V. P. Syriopoulou, M. D. Mavrouli, E. Th. Petridou

Erschienen in: Cancer Causes & Control | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Delayed exposure to common infections during childhood, have been implied to cause strong immunological response to a single infectious agent that eventually triggers leukemogenesis. The aim of the present study was to investigate whether decreased exposure to infections, as reflected in a more seronegative spectrum to several common infectious agents, is associated with increased risk for the development of childhood lymphomas.

Methods

All 125 children (up to 14 years old), with Hodgkin (HL, n = 52) and non-Hodgkin lymphomas (NHL, n = 73) diagnosed through the national network of childhood Hematology–Oncology units during an 8-year period were enrolled in the study along with 125 age- and gender-matched controls. Past exposure to nine common infections [respiratory syncytial virus (RSV), influenza A and B, parainfluenza type 1, adenovirus, Epstein–Barr virus (EBV), cytomegalovirus (CMV), human herpes virus 6 (HHV6), Bartonella henselae] was assessed using serological markers.

Results

After controlling for possible confounding factors, the overall seronegativity status upon diagnosis was statistically significantly associated with NHL [odds ratio; 95% CI: 1.45 (1.10–1.93), p = 0.01] and less so with HL risk [odds ratio; 95% CI: 1.30 (0.83–2.05), p = 0.25]. A statistically significant association of seronegativity with the development of NHL was evident for RSV [odds ratio; 95% CI: 7.27 (1.59–33.28), p = 0.01], EBV [odds ratio; 95% CI: 6.73 (1.45–31.20), p = 0.01] and suggestive association for influenza B [odds ratio; 95% CI: 2.60 (0.90–7.55), p = 0.08] and influenza A [odds ratio; 95% CI: 2.35 (0.81–6.80), p = 0.11]. In contrast, there was no evidence for association of HL with negative serology for any of the infectious agents tested.

Conclusions

The risk of lymphomas, especially NHL, might be higher when, due to lower exposure to several infectious agents, the relatively unmodulated immune system of a child is challenged by environmental stimuli that can trigger development of lymphomas. The results, however, need further confirmation, through more pertinent methodological designs.
Literatur
1.
Zurück zum Zitat Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, Turner JJ, Milliken S, Benke G, Armstrong BK (2005) Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 97:587–594PubMedCrossRef Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, Turner JJ, Milliken S, Benke G, Armstrong BK (2005) Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 97:587–594PubMedCrossRef
9.
10.
Zurück zum Zitat Monnereau A, Orsi L, Troussard X, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Clavel J (2007) History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk? Leukemia 21:2075–2079. doi:10.1038/sj.leu.2404738 PubMedCrossRef Monnereau A, Orsi L, Troussard X, Berthou C, Fenaux P, Marit G, Soubeyran P, Huguet F, Milpied N, Leporrier M, Hemon D, Clavel J (2007) History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk? Leukemia 21:2075–2079. doi:10.​1038/​sj.​leu.​2404738 PubMedCrossRef
11.
Zurück zum Zitat Hjalgrim H, Smedby KE, Rostgaard K, Molin D, Hamilton-Dutoit S, Chang ET, Ralfkiaer E, Sundstrom C, Adami HO, Glimelius B, Melbye M (2007) Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res 67:2382–2388. doi:10.1158/0008-5472.CAN-06-3566 PubMedCrossRef Hjalgrim H, Smedby KE, Rostgaard K, Molin D, Hamilton-Dutoit S, Chang ET, Ralfkiaer E, Sundstrom C, Adami HO, Glimelius B, Melbye M (2007) Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res 67:2382–2388. doi:10.​1158/​0008-5472.​CAN-06-3566 PubMedCrossRef
12.
Zurück zum Zitat Petridou E, Andrie E, Dessypris N, Dikalioti SK, Trichopoulos D (2006) Incidence and characteristics of childhood Hodgkin’s lymphoma in Greece: a nationwide study (Greece). Cancer Causes Control 17:209–215. doi:10.1007/s10552-005-0409-0 PubMedCrossRef Petridou E, Andrie E, Dessypris N, Dikalioti SK, Trichopoulos D (2006) Incidence and characteristics of childhood Hodgkin’s lymphoma in Greece: a nationwide study (Greece). Cancer Causes Control 17:209–215. doi:10.​1007/​s10552-005-0409-0 PubMedCrossRef
14.
Zurück zum Zitat Becker N, de Sanjose S, Nieters A, Maynadie M, Foretova L, Cocco PL, Staines A, Alvaro T, Vornanen M, Brennan P, Boffetta P (2007) Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res 31:1365–1372. doi:10.1016/j.leukres.2007.02.019 PubMedCrossRef Becker N, de Sanjose S, Nieters A, Maynadie M, Foretova L, Cocco PL, Staines A, Alvaro T, Vornanen M, Brennan P, Boffetta P (2007) Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res 31:1365–1372. doi:10.​1016/​j.​leukres.​2007.​02.​019 PubMedCrossRef
16.
Zurück zum Zitat Petridou E, Dalamaga M, Mentis A, Skalkidou A, Moustaki M, Karpathios T, Trichopoulos D (2001) Evidence on the infectious etiology of childhood leukemia: the role of low herd immunity (Greece). Cancer Causes Control 12:645–652. doi:10.1023/A:1011255825887 PubMedCrossRef Petridou E, Dalamaga M, Mentis A, Skalkidou A, Moustaki M, Karpathios T, Trichopoulos D (2001) Evidence on the infectious etiology of childhood leukemia: the role of low herd immunity (Greece). Cancer Causes Control 12:645–652. doi:10.​1023/​A:​1011255825887 PubMedCrossRef
19.
Zurück zum Zitat Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S (2004) Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103:3117–3121. doi:10.1182/blood-2003-09-3302 PubMedCrossRef Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S (2004) Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103:3117–3121. doi:10.​1182/​blood-2003-09-3302 PubMedCrossRef
22.
Zurück zum Zitat Petridou ET, Pourtsidis A, Dessypris N, Katsiardanis K, Baka M, Moschovi M, Polychronopoulou S, Koliouskas D, Sidi V, Athanasiadou-Piperopoulou F, Kalmanti M, Belechri M, La Vecchia C, Curado MP, Skalkidis I (2008) Childhood leukaemias and lymphomas in Greece (1996–2006): a nationwide registration study. Arch Dis Child 93:1027–1032. doi:10.1136/adc.2007.133249 PubMedCrossRef Petridou ET, Pourtsidis A, Dessypris N, Katsiardanis K, Baka M, Moschovi M, Polychronopoulou S, Koliouskas D, Sidi V, Athanasiadou-Piperopoulou F, Kalmanti M, Belechri M, La Vecchia C, Curado MP, Skalkidis I (2008) Childhood leukaemias and lymphomas in Greece (1996–2006): a nationwide registration study. Arch Dis Child 93:1027–1032. doi:10.​1136/​adc.​2007.​133249 PubMedCrossRef
25.
Zurück zum Zitat Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52:5432s–5440sPubMed Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res 52:5432s–5440sPubMed
26.
Zurück zum Zitat Vineis P, Miligi L, Crosignani P, Fontana A, Masala G, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, Vindigni C, Costantini AS (2000) Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 54:907–911. doi:10.1136/jech.54.12.907 PubMedCrossRef Vineis P, Miligi L, Crosignani P, Fontana A, Masala G, Nanni O, Ramazzotti V, Rodella S, Stagnaro E, Tumino R, Vigano C, Vindigni C, Costantini AS (2000) Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 54:907–911. doi:10.​1136/​jech.​54.​12.​907 PubMedCrossRef
27.
Zurück zum Zitat Paffenbarger RS Jr, Wing AL, Hyde RT (1978) Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication. J Natl Cancer Inst 60:89–92PubMed Paffenbarger RS Jr, Wing AL, Hyde RT (1978) Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication. J Natl Cancer Inst 60:89–92PubMed
30.
Zurück zum Zitat Bracci PM, Dalvi TB, Holly EA (2006) Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case–control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 15:1287–1294. doi:10.1158/1055-9965.EPI-06-0066 PubMedCrossRef Bracci PM, Dalvi TB, Holly EA (2006) Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case–control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 15:1287–1294. doi:10.​1158/​1055-9965.​EPI-06-0066 PubMedCrossRef
31.
Zurück zum Zitat Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed
33.
Zurück zum Zitat Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH, Melbye M (2003) Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 349:1324–1332. doi:10.1056/NEJMoa023141 PubMedCrossRef Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, Madsen M, Rosdahl N, Konradsen HB, Storm HH, Melbye M (2003) Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 349:1324–1332. doi:10.​1056/​NEJMoa023141 PubMedCrossRef
34.
Zurück zum Zitat MacMahon B, Trichopoulos D (1996) Epidemiology: principles and methods. Little Brown and Co, Boston MacMahon B, Trichopoulos D (1996) Epidemiology: principles and methods. Little Brown and Co, Boston
Metadaten
Titel
Delayed exposure to infections and childhood lymphomas: a case–control study
verfasst von
A. Michos
N. Dessypris
A. Pourtsidis
M. Moschovi
S. Polychronopoulou
F. Athanasiadou-Piperopoulou
M. Kalmanti
V. P. Syriopoulou
M. D. Mavrouli
E. Th. Petridou
Publikationsdatum
01.07.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9294-2

Weitere Artikel der Ausgabe 5/2009

Cancer Causes & Control 5/2009 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.